Source : Medtech Insight
More virtual town halls are on the way from the US Food and Drug Administration that are aimed at labs and manufacturers that are (or have) developed diagnostic tests for COVID-19.
The FDA announced on 29 July that it will continue its town hall series on the regulation and development of diagnostics for the novel coronavirus throughout the month of August. The agency has held 18 of the webinars – one a week – since the end of March. (Click here for replays and transcripts of each of those past meetings.)
The next four town halls will take place on 5, 12, 19 and 26 August. All of them will begin at 12:15 pm EST and be an hour in length. Registration isn’t necessary.
Here’s the dial-in information:
US callers: 888-455-1392; conference No. RWXW1570452; passcode: 4621446
International callers: 1-773-799-3847; conference No. RWXW1570452; passcode: 4621446
The FDA says attendees should visit www.mymeetings.com/nc/join.php?i=RWXW1570452&p=4621446&t=c to view the slide presentation during the webinar.
By Shawn M. Schmitt